Chittorgarh.com Logo
Loading...

Vanta Bioscience IPO Details

Issue Open Sep 25, 2017
Issue Close Sep 27, 2017
IPO Price ₹50
Face Value ₹10
IPO Size ₹7.56 Cr
Listing At BSE SME
IPO Lot Size 3000

VANTA BIOSCIENCE LIMITED

Corporate Identification Number: U74999TG2016PLC109280

Our Company was originally incorporated as a private limited company under the Companies Act 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name 'Vanta Biosciencs Private Limited'. Our Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on february 13, 2017 and consequently, the name of our Company was changed to 'Vanta Bioscience Limited' and a fresh certificate of incorporation consequent upon conversion in public Smiled company was issued by the Registrar of Companies, Hyderabad on March) 17,2017.for further details of our Company, see 'General Information' and 'History and Certain Other Corporate Matters' on pages 41 and 86. respectively.

Registered Office: No 02/G/308/G, NO.3/FF/SF/1-20-248 Umajay Complex, Rasoolpura, Secunderabad, Hyderabad - 500 003, Telangana, India.
Tel.: +91 40 6657 5454 | Fax: +91 40 2790 8708 | E-mail: info@vantabio.com | Website: www.vantabio.com
Contact Person; Zoheb Sayani. Company Secretary and Compliance Officer | Tel: +91 40 6657 5454.

PROMOTERS OF THE COMPANY: MOHAN KRISHNA MULAKALA. DOPESH RAJA MULAKALA,
0R.VYASMURTI MADHAVRAO SHINGATGERI DR. SOUMYA SIMHADRI, SHRAVAN CHINTAPATLA,
KARISHMA MULAKALA, SAJAN KIRAN MULAKALA. PRADEEP CHOWDARY AND OR. CHANDRASEKHAR RAO SIMHADRI

BASIS OF ALLOTMENT

PUBLIC ISSUE OF 15.12.000 EQUITY SHARES OF FACE VALUE OF RS 10.00 EACH OF VANTA BIOSCIENCE LIMITED ('OUR COMPANY' OR 'THE ISSUER') FOR CASH AT A PRICE OF RS 50.00 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 40.00 PEP EQUITY SHARE) ('ISSUE PRICE') AGGREGATING TO RS 756.00 LAKHS ('THE ISSUE'). OF THE ISSUE, 78.000 EQUITY SHARES AGGREGATING TO RS 39.00 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKER ('MARKET MAKER RESERVATION PORTION') THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION I. E. ISSUE OF 14,34,000 EQUITY SHARES OF FACE VALUE OF RS 10.00 EACH AT AN ISSUE PRICE OF RS 50.00 PER EQUITY SHARE AGGREGATING TO RS 717.00 LAKHS IS HEREINAFTER REFERRED TO AS THE 'NET ISSUE'. THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 26.40% AND 25.03%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.
THIS BEING A FIXED PRICE, AS PER SUB CLAUSE (4) OF REGULATION 43 OF THE SEBI (ICDR) REGULATIONS, 2009 AS AMENDED (THE ' SEBI REGULATIONS'). OUT OF THE NET ISSUE OF 14,34,000 EQUITY SHARES, NOT LESS THAN 50% SHALL BE AVALABLE TO RETAIL INDIVIDUAL INVESTORS AND THE REMAINING TO INDIVIDUAL APPLICANTS OTHER THAN RETAIL INVESTORS AND OTHER INVETORS INCLUDING CORPORATE BODIES OR INSTITUTIONS IRRESPECTIVE OF THE NUMBER OF SHARES APPLIED FOR. IF THE RETAIL INDIVIDUAL INVESTOR CATEGORY IS ENTITLED TO MORE THAN 50% ON PROPORATIONATE BASIS, THEY SHALL BE ALLOTTED THAT HIGHER PERCENTAGE.

THE FACE VALUE OF THE EQUITY SHARES IS RS 10 EACH AND
THE ISSUE PRICE OF RS 50 IS 5 TIMES OF THE FACE VALUE
ISSUE OPENED ON SEPTEMBER 25, 2017 AND CLOSED ON SEPTEMBER 27 2017
PROPOSED LISTING: FRIDAY, OCTOBER 6, 2017*

The Equity Shares offered through this Prospectus are proposed to be listed on the BSE SME Platform. In terms of the Chapter XB of the SEBI (ICDR) Regulations. 2009. as amended from time to time, we are not required to obtain an in-principal listing approval for the shares being Offered in this Issue. However, our Company has received an approval letter dated August 24, 2017 from BSE for using its name in this Prospectus for listing of our Equity Shares on the SME Patform of BSE For the purpose of this Issue, BSE Limited shall be the Designated Stock Exchange. The trading is proposed to be commenced with effect from FRIDAY, OCTOBER 6.2017*.
*Subject to receipt of listing and trading approvals from the BSE.
All Applicants (except for underwriters for the underwriting portion) participated in the Issue through APPLICATIONS SUPPORTED BY BLOCKED AMOUNT ('ASBA') process by providing the details of their respective bank accounts in which the corresponding application amounts were blocked by Sell Certified Syndicate Banks (the 'SCSBs').

SUBSCRIPTION DETAILS

The Issue has received 345 applications for 16386000 Equity Shares resulting in 1.12 times subscription (including reserved portion of Markal Maker). Due to technical rejections the issue was undersubscribed Since this Issue was fully underwritten, and requisite notice was sent to Underwriter i.e. Inventure Growth & Securities Limited hence Underwriter has arranged for subscription for the shortfall of Equity Shares and accordingly Issue was fully subscribed. The details of the applications received in the Issue (before technical rejections and after returns due to unblocked amount) are as follows:
Detail of the Applications Received (Before Technical Rejection):

Category No. of Applications % No. of Equity Shares % Subscription
Non Retail Investor's 99 28.61% 873000 40.81% 1.22
Retail Individual Investor's 245 70.81% 735000 34.36% 1.03
Market Maker 1 0.29% 78000 3.65% 1.00
Underwriter 1 0.29% 453000 21.18% 1.00
TOTAL 345 100.00% 2139000 100.00% 1.41

The details of applications rejected by the Registrar on technical grounds / withdrawal are detailed below: Technical rejection,/ Withdrawal

Category No. of Applications Na. of Equity Shares
Market Maker Nil Nil
Non Retail Investors 79 519000
Retail Individual Investors 36 108000
TOTAL 115 627000

After eliminating Technically Rejected applications, the following table gives the details of Category wise net valid applications; Alter technical rejections

Category No.of
Applications
% No.of Equity
Shares (Valid)
% Subscription Proportionate No.of Equriy Shares
(Allocated) After Rounding Off)
Market Maker 1 0.43% 78000 5.16% 1.00 78000
Non Retail Investors 20 8.66% 354000 23.41% 1.00 354000
Retail Individual Investors 209 90.48% 627000 41.47% 1.00 627000
Underwriter Devolvement 1 0.43% 453000 29.96% 1.00 453000
TOTAL 231 100.00% 512000 100.00 1.00 1512000

Since the issue is fully underwritten the shortfall of 453000 equity shares aggregating to Rs 22650000.00 was arranged by the Underwriter in terms of the Underwriting agreement dated August 24.2017.

Allocation: The Basis of Allotment was finalized In consultation with the Designated Stock Exchange - BSE on October4,2017.
A. Allocation to Market Maker (After Technical Rejections): The Basis of Allotment to the Market Maker at the issue price of Rs 50 per Equity Share, was finalized in consultation with BSE. The category was subscribed by 1 .00 times. The total number of shares allotted in this category is 78,000 Equity Shares.

B. Allocation to Retail Individual Investors (After Technical Rejections): The Basis of Allotment to the Retail Individual Investors, at the Issue price of Rs 50 per Equity Share, was finalized in consultation with BSE. The category was subscribed 0.874 times. Due to under subscription all the 209 valid applicants In this category have been given full and firm allotment of 4,000 equity shares each and the under subscribed portion, of 90,000 equity shares from Retail Individual Investors Category have been spilled over to Underwriter Category. The total number of shares allotted in this category is 627000 Equity Shares to 209 successful applicants.

C. Allocation to Non Retail Investors (After Technical Rejections): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs 50 per Equity Share, was finalized in consultation with BSE. The category was subscribed 0.494 times. The under subscribed 363000 Equity shares from Non Retail Investors Category have been spilled over to Underwriters Category), The total number of shares allotted in this category is 3,54,000 Equity Shares,
The Category-wise details of the Basis of Allotment are as under:

No. of Shanes
Applied for (Category wise)
No. of
Applications Receives
% to Total
Total No. of
Shares
Applied in
each Category
% of
Total
Proporti nate
Shares
Available
Allocation per
Applicant
(Before
Rounding Off)
Allocation
per
Applicant
(After
Rounding Off)
Ratio of
Allottees to  Applicants
Total No.of
Shares allocated/
allolled
Surplus/ Defecit
6000 10 50.00 60000 16.95 121525 6000 6000 1:1 60000 -61525
9000 5 25.00 45000 12,71 91144 9000 9000 1:1 45000 -46144
12000 1 5,00 12000 3.39 24305 12000 12000 1:1 12000 -12305
21000 1 5.00 21000 5.93 42534 21000 21000 1:1 21000 -21534
39000 1 5.00 39000 11.02 78992 39000 39000 1:1 39000 -39992
78000 1 5.00 78000 22.03 157983 78000 78000 1:1 78000 -79983
99000 1 5.00 99000 27.97 200517 99000 99000 1:1 99000 -101517
TOTAL 20 100.00 354000 100,00 717000 354000 -3,63,000

D. Allocation to Underwriters (After Technical Rejections): The subscription for the shortfall of 453000 Equity Shares has been arranged by Underwriter at the issue price of Rs 50 per Equity Shares. The under subscribed 90000 & 363000 shares respectively from both Retail category & Non Retail category have been allotted to Underwriter category. The Basis of Allotment for Underwriter Category at the issue price of Rs 50 per Equity Share, was finalized in consultation with BSE. The total number of shares allotted in this category is 4,53,000 Equity Shares to one Applicant.
The Board of Directors of the Company at Its meeting held on October 5,2017 has taken on record the basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. BSE and has authorized the corporate action for the transfer of the Equity Shares to various successful applicants.
The CAN and allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories on October 5,2017. Further, the instructions to Self Certified Syndicate Banks are being processed on October 5, 2017. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the SME Platform of BSE within six working days from the date of the closure of the Issue.
Note: All capitalized terms used and not defined herein shall have the respective meaning assigned to them In the Prospectus dated September 1.2017 ('Prospectus').

INVESTORS PLEASE NOTE

The details of the allotment mads would also be hosted on the website of the Registrar to the issue, BIGSHARE SERVICES PRIVATE LIMITED at www.bigshareonline.com. All future correspondence In this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Rank Branch where the application had been lodged and payment details at the address of the Registrar given below:

BIGSHARE SERVICES PRIVATE LIMITED
Bharat Tin Works Bldg. 1st Floor, opp. Vasant Oasis Makwana Road. Marol, (Andheri East), Mumbai-4000059.
Tel: +91 22 62638200 | Fax: +91 22 62638299 E-mail: ipo@bigshareonline.com
Website: www.bigshareonline.com | Contact Person: Mr Babu Raphel | SEBI Registration No,: INR000001385

Place: Hyderabad

Date : October 05. 2017

For Vanta Bioscience Limited
On behalf of the Board of Directors
Sd/-
Managing Director

Vanta Bioscience IPO Basis of Allotment FAQs

Check the basis of allotment document above to know about how the shares are allocated in Vanta Bioscience IPO. Note that there is a separate rule for allotment in each investor category (i.e. Retail, Non-Institutional, Institutional, Employee).

The Vanta Bioscience IPO basis of allotment (published above) tells you how shares are allocated to you in Vanta Bioscience IPO and category wise demand of IPO share.

Visit the Vanta Bioscience IPO allotment status page to check the number of shares allocated to your application.

Check the basis of allotment document above to know about how the shares are allocated in Vanta Bioscience IPO. Note that there is a separate rule for allotment in each investor category (i.e. Retail, Non-Institutional, Institutional, Employee).